Publications by authors named "James Suh"

Claim this Profile
A
A proteogenomic portrait of lung squamous cell carcinoma.
Shankha Satpathy, Karsten Krug, Pierre M Jean Beltran, Sara R Savage, Francesca Petralia, Suhas V Vasaikar, James Suh

Cell· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive genomic profiling of metastatic collecting duct carcinoma, renal medullary carcinoma, and clear cell renal cell carcinoma.
Gennady Bratslavsky, Stephanie Gleicher, Joseph M Jacob, Thomas H Sanford, Oleg Shapiro, James Suh

Urol Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy.
Andrea Necchi, Gennady Bratslavsky, Robert J Corona, Jon H Chung, Sherri Z Millis, James Suh

Eur Urol Focus· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers.
Aatur D Singhi, Ben George, Joel R Greenbowe, Jon Chung, James Suh

Gastroenterology· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma.
Celina Ang, Samuel J Klempner, Siraj M Ali, Russell Madison, Jeffrey S Ross, James Suh

Oncotarget· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLC.
Michael E Goldberg, Meagan Montesion, Lauren Young, James Suh, Joel Greenbowe

PLoS One· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metaplastic breast cancers: Genomic profiling, mutational burden and tumor-infiltrating lymphocytes.
Nancy Tray, Jessica Taff, Baljit Singh, James Suh, Nhu Ngo

Breast· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hybrid Capture-Based Comprehensive Genomic Profiling Identifies Lung Cancer Patients with Well-Characterized Sensitizing Epidermal Growth Factor Receptor Point Mutations That Were Not Detected by Standard of Care Testing.
James H Suh, Alexa B Schrock, Adrienne Johnson, Doron Lipson, Laurie M Gay

Oncologist· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.
Jeffrey S Ross, Marwan Fakih, Siraj M Ali, Julia A Elvin, Alexa B Schrock, James Suh

Cancer· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
in Lung Cancers: Analysis of Patient Cases Reveals Recurrent Mutations, Fusions, Kinase Duplications, and Concurrent Alterations.
Yuri Sheikine, Dean Pavlick, Samuel J Klempner, Sally E Trabucco, Jon H Chung, James H Suh

JCO Precis Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures.
Adrienne Johnson, Eric Severson, Laurie Gay, Jo-Anne Vergilio, Julia Elvin, James Suh

Oncologist· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
General paucity of genomic alteration and low tumor mutation burden in refractory and metastatic hepatoblastoma: comprehensive genomic profiling study.
Hwajeong Lee, Tony El Jabbour, Sanaz Ainechi, Laurie M Gay, Julia A Elvin, James Suh

Hum Pathol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy.
Jeffrey S Ross, Siraj M Ali, Omotayo Fasan, Jared Block, Sumanta Pal, James Suh

Oncologist· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy.
Siraj M Ali, Ming Yao, Jicheng Yao, Jing Wang, Yuwei Cheng, James Suh

Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options.
Laurie M Gay, Sungeun Kim, Kyle Fedorchak, Madappa Kundranda, Yazmin Odia, James Suh

Oncologist· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.
Alexa B Schrock, Shuyu D Li, Garrett M Frampton, James Suh, Eduardo Braun

J Thorac Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer Pathogenesis.
Ryan J Hartmaier, Lee A Albacker, Juliann Chmielecki, Mark Bailey, Jie He, James Suh

Cancer Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive genomic profiling of malignant phyllodes tumors of the breast.
Sahar Nozad, Christine E Sheehan, Laurie M Gay, Julia A Elvin, Jo-Anne Vergilio, James Suh

Breast Cancer Res Treat· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib.
Sai-Hong Ignatius Ou, Alexa B Schrock, Eduard V Bocharov, Samuel J Klempner, Carolina Kawamura Haddad, James H Suh

J Thorac Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion.
Vivek Subbiah, Oliver Holmes, Kyle Gowen, Daniel Spritz, Behrang Amini, James H Suh

Oncology· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivation of Capicua drives cancer metastasis.
Ross A Okimoto, Frank Breitenbuecher, Victor R Olivas, Wei Wu, Beatrice Gini, James Suh

Nat Genet· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-Generation Sequencing Reveals Pathway Activations and New Routes to Targeted Therapies in Cutaneous Metastatic Melanoma.
J Andrew Carlson, Jose Candido Caldeira Xavier, Ashley Tarasen, Christine E Sheehan, Geoff Otto, James Suh

Am J Dermatopathol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra.
Juliann Chmielecki, Mark Bailey, Jie He, Julia Elvin, Jo-Anne Vergilio, James Suh

Cancer Res· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yield and Clinical Utility of Next-Generation Sequencing in Selected Patients With Lung Adenocarcinoma.
David M DiBardino, Anjali Saqi, Julia A Elvin, Joel Greenbowe, James H Suh

Clin Lung Cancer· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations.
Alexa B Schrock, Garrett M Frampton, James Suh, Zachary R Chalmers, Mark Rosenzweig

J Thorac Oncol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis